Protocolo clínico e diretrizes terapêuticas: esclerose múltipla

Comissão Nacional de Incorporação de Tecnologias no SUS

Protocolo clínico e diretrizes terapêuticas: esclerose múltipla / Clinical protocol and therapeutic guidelines: multiple sclerosis

Comissão Nacional de Incorporação de Tecnologias no SUS.

Brasília; Brasil. Ministério da Saúde; 2018.

Non-conventional in Portuguese | LILACS, ColecionaSUS | ID: biblio-882580

Subject(s)

Humans; Clinical Protocols/standards; Multiple Sclerosis/diagnosis; Multiple Sclerosis/drug therapy; Azathioprine/therapeutic use; Brazil; Continuity of Patient Care; Dimethyl Fumarate/therapeutic use; Fingolimod Hydrochloride/therapeutic use; Glatiramer Acetate/therapeutic use; Interferon-beta/therapeutic use; Methylprednisolone/therapeutic use; Natalizumab/therapeutic use; Practice Guidelines as Topic/standards

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Clinical Protocols / Multiple Sclerosis Type of study: Practice guideline Limits: Humans Country/Region as subject: South America / Brazil Language: Portuguese Year: 2018 Type: Non-conventional

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google